Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 4
1993 1
1994 3
1995 3
1996 9
1997 6
1998 4
2000 6
2001 1
2002 4
2003 5
2004 5
2005 5
2006 5
2007 5
2008 6
2009 3
2010 4
2011 6
2012 5
2013 8
2014 13
2015 8
2016 10
2017 9
2018 11
2019 4
2020 6
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
The Future of Nuclear Medicine, Molecular Imaging, and Theranostics.
Weber WA, Czernin J, Anderson CJ, Badawi RD, Barthel H, Bengel F, Bodei L, Buvat I, DiCarli M, Graham MM, Grimm J, Herrmann K, Kostakoglu L, Lewis JS, Mankoff DA, Peterson TE, Schelbert H, Schöder H, Siegel BA, Strauss HW. Weber WA, et al. Among authors: kostakoglu l. J Nucl Med. 2020 Dec;61(Suppl 2):263S-272S. doi: 10.2967/jnumed.120.254532. J Nucl Med. 2020. PMID: 33293447 Free article. Review. No abstract available.
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cheson BD. Barrington SF, et al. Among authors: kostakoglu l. J Clin Oncol. 2014 Sep 20;32(27):3048-58. doi: 10.1200/JCO.2013.53.5229. J Clin Oncol. 2014. PMID: 25113771 Free PMC article.
Guest Editorial.
Kostakoglu L. Kostakoglu L. Semin Nucl Med. 2018 Jan;48(1):2-3. doi: 10.1053/j.semnuclmed.2017.10.001. Epub 2017 Oct 27. Semin Nucl Med. 2018. PMID: 29195614 No abstract available.
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.
Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, Kostakoglu L, Serafini AN, Pampaloni MH, Jensen J, Armor T, Lin T, White T, Stambler N, Apfel S, DiPippo VA, Mahmood S, Wong V, Jimenez C. Pryma DA, et al. Among authors: kostakoglu l. J Nucl Med. 2019 May;60(5):623-630. doi: 10.2967/jnumed.118.217463. Epub 2018 Oct 5. J Nucl Med. 2019. PMID: 30291194 Free PMC article. Clinical Trial.
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Straus DJ, Jung SH, Pitcher B, Kostakoglu L, Grecula JC, Hsi ED, Schöder H, Popplewell LL, Chang JE, Moskowitz CH, Wagner-Johnston N, Leonard JP, Friedberg JW, Kahl BS, Cheson BD, Bartlett NL. Straus DJ, et al. Among authors: kostakoglu l. Blood. 2018 Sep 6;132(10):1013-1021. doi: 10.1182/blood-2018-01-827246. Epub 2018 Jul 26. Blood. 2018. PMID: 30049811 Free PMC article. Clinical Trial.
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412.
Nowakowski GS, Hong F, Scott DW, Macon WR, King RL, Habermann TM, Wagner-Johnston N, Casulo C, Wade JL, Nagargoje GG, Reynolds CM, Cohen JB, Khan N, Amengual JE, Richards KL, Little RF, Leonard JP, Friedberg JW, Kostakoglu L, Kahl BS, Witzig TE. Nowakowski GS, et al. Among authors: kostakoglu l. J Clin Oncol. 2021 Apr 20;39(12):1329-1338. doi: 10.1200/JCO.20.01375. Epub 2021 Feb 8. J Clin Oncol. 2021. PMID: 33555941 Free PMC article. Clinical Trial.
Metabolic Tumor Volume Metrics in Lymphoma.
Kostakoglu L, Chauvie S. Kostakoglu L, et al. Semin Nucl Med. 2018 Jan;48(1):50-66. doi: 10.1053/j.semnuclmed.2017.09.005. Semin Nucl Med. 2018. PMID: 29195618 Review.
154 results